pancreatic-cancer

Documents about pancreatic-cancer

• Assessing Pancreatic Fistula Rates After Distal Pancreatectomy Using AEON Endostapler#882785ClinicalTrials.gov
• Superior Mesenteric Artery First Versus Standard Approach in Pancreaticoduodenectomy#885459ClinicalTrials.gov
• Study Combining Suicide Gene Therapy With Chemoradiotherapy in the Treatment of Non-Metastatic Pancreatic Adenocarcinoma#902535ClinicalTrials.gov
• Exploring the Costs of Hospital and Emergency Department Utilisation in the First Three Years After Diagnosis for Adults Diagnosed With Pancreatic Cancer in Queensland, Australia#483484Open Research
• Defining a Vascular Phenotype of Pancreatic Ductal Adenocarcinoma With CT Perfusion Using Quantitative Radiomics#802025ClinicalTrials.gov
• Gene Expression Profile of Resected Pancreatic and Ampullary Adenocarcinoma at Favorable Prognosis#877279ClinicalTrials.gov
• Repeated EUS-guided Fine Needle Biopsy of Pancreatic Masses After Non-diagnostic or Inconclusive Results#896047ClinicalTrials.gov
• Primary Thromboprophylaxis in Pancreatic Cancer Patients: Why Clinical Practice Guidelines Should Be Implemented#179477HAL (France)
• Durable Response to Nivolumab Combined With Metformin in Advanced Pancreatic Cancer: A Case Report With Seven Years of Follow-Up#465446OKAYAMA UNIVERSITY SCIENTIFIC ACHIEVEMENT REPOSITORY
• Pilot Study of Autologous T-cells in Patients With Metastatic Pancreatic Cancer#801008ClinicalTrials.gov
• Study to Evaluate the Safety, PK, and Efficacy of the Myc Inhibitor OMO-103 Administered iv in Patients With PDAC#801494ClinicalTrials.gov
• HR070803 in Combination With Oxaliplatin, 5-FU/LV Versus AG for First-line Treatment of Advanced Pancreatic Cancer#813808ClinicalTrials.gov
• Physical Activity and Nutrition to Halt Elevated Risk in the Pancreas Interception Center#854525ClinicalTrials.gov
• Combined Chemotherapy And Ablative Radiotherapy (SBRT) As First-Line Treatment In Locally Advanced Inoperable Pancreatic Cancer (SBRT-PANC)#855264ClinicalTrials.gov
• In Vitro Models of Liver and Pancreatic Cancer#855871ClinicalTrials.gov
• INSPIRE: a Multi-Cancer Early Detection Study#854463ClinicalTrials.gov
• Cancer Loyalty Card Study 2 (CLOCS-2)#889575ClinicalTrials.gov
• Feasibility of the LUM Imaging System for Detection of Gastrointestinal Cancers#837571ClinicalTrials.gov
• Phase Ib/II Clinical Study of Adebrelimab in Combination With Decitabine, Albumin-bound Paclitaxel, and Gemcitabine for the First-line Treatment of Metastatic Pancreatic Cancer#143578ClinicalTrials.gov
• FAK activity in cancer-associated fibroblasts is a prognostic marker and a druggable key metastatic player in pancreatic cancer#311988HAL (France)
• Evaluation of a Mixed Meal Test for Diagnosis and Characterization and Type 3c Diabetes Mellitus Secondary to Pancreatic Cancer and Chronic Pancreatitis (DETECT)#879742ClinicalTrials.gov
• Neural-immune-cancer crosstalk in pancreatic cancer: mechanisms and clinical translation.#152240NCBI PubMed Central
• Zimberelimab and Quemliclustat in Combination With Chemotherapy for the Treatment of Patients With Borderline Resectable and Locally Advanced Pancreatic Adenocarcinoma#252978ClinicalTrials.gov
• Cutting Edge Imaging With PET-FAPI for Earlier Pancreatic Cancer Diagnosis (INDIGO-FAPI)#861688ClinicalTrials.gov
• PDAC Regression and Intraoperative Surgical Margin With Neoadjuvant TAMP (PRISM-TAMP)#886025ClinicalTrials.gov
• Volatile Organic Compound Assessment in Pancreatic Ductal Adenocarcinoma#895285ClinicalTrials.gov
• Liposomal Irinotecan, Fluorouracil and Leucovorin in Treating Patients With Refractory Advanced High Grade Neuroendocrine Cancer of Gastrointestinal, Unknown, or Pancreatic Origin#886187ClinicalTrials.gov
• Cyclophosphamide Plus Vaccine Therapy in Treating Patients With Advanced Cancer#28305ClinicalTrials.gov
• Autologous Natural Killer T Cells Infusion for the Treatment of Cancer#28337ClinicalTrials.gov
• Supervised (Home-Based Exercise) Prehabilitation Program in Pancreatic Cancer Patients Undergoing to Neoadjuvant Chemotherapy: A Pilot Feasibility Study#185660IRIS
• Gemcitabine, Nab-paclitaxel and KPT-330 in Advanced Pancreatic Cancer#837502ClinicalTrials.gov
• A Study to Evaluate the Efficacy and Safety of CT041 After Adjuvant Chemotherapy for Pancreatic Cancer#879040ClinicalTrials.gov
• The Effects of Neoadjuvant Metformin on Tumour Cell Proliferation and Tumour Progression in Pancreatic Ductal Adenocarcinoma#67834ClinicalTrials.gov
• The Vitamin D3 Analog Calcipotriol Attenuates Pancreatic Cancer Malignancy via Downregulating Thrombospondin 1 in Pancreatic Stellate Cells.#135928NCBI PubMed Central
• CCR2 PET for Pancreatic Cancer Imaging and Prediction of Response to Standard and CCR2-Targeted Therapy#307456ClinicalTrials.gov
• Repurposing Rilmenidine as a Potential Antimetastatic Therapy Targeting Nischarin in Pancreatic Ductal Adenocarcinoma#356119Zenodo (CERN)
• Randomized Trial of EUS Neurolysis in Pancreas Cancer#839691ClinicalTrials.gov
• EUS-guided Intra-tumour Injection of OncoSil for Locally Advanced Pancreatic Carcinoma.#845183ClinicalTrials.gov
• Impact of Multidisciplinary and Radiologic Review on Outcome of Pancreatic Cancer Patients: an Observational Study#871485ClinicalTrials.gov
• A Study of the Efficacy of ONS to Reduce Postoperative Complications Associated With Pancreatic Surgery#877520ClinicalTrials.gov
• Gemcitabine, Nab-Paclitaxel, Cisplatin and Anakinra Treatment on Patients With Pancreatic Cancer#886457ClinicalTrials.gov
• Gemcitabine and Nabpaclitaxel in Metastatic Pancreatic Carcinoma.#888711ClinicalTrials.gov
• Phase 2 Study of Gemcitabine or Gemcitabine + Enzastaurin in Participants With Advanced or Metastatic Pancreatic Cancer#895271ClinicalTrials.gov
• Safety Study of a Liposomal Docetaxel Formulation in Patients With Solid Tumors Who Have Failed Previous Therapies#897169ClinicalTrials.gov
• A Study to Compare the Efficacy and Safety of YL201 With Standard Chemotherapy in Patients With Metastatic Pancreatic Cancer After Failure of Gemcitabine-Based Systemic Chemotherapy#848375ClinicalTrials.gov
• ARQ 501 in Combination With Gemcitabine in Subjects With Pancreatic Cancer#900914ClinicalTrials.gov
• Intestinal Microbiota Impact for Prognosis and Treatment Outcomes in Early Luminal Breast Cancer and Pancreatic Cancer Patients#172318ClinicalTrials.gov
• Disclosing a pancreatic cancer diagnosis in an era of immediate electronic result release: a national survey of endosonographers.#193891PubMed
• A Study Comparing Whole-Body Heat Treatment Plus Systemic Therapy to Systemic Therapy Alone, for Advanced Pancreatic Cancer#864347ClinicalTrials.gov
• Study of Quemliclustat and Chemotherapy Versus Placebo and Chemotherapy in Patients With Metastatic Pancreatic Ductal Adenocarcinoma#877329ClinicalTrials.gov